Nov 14, 2022 / 09:30PM GMT
Operator
Good day, and welcome to the Eledon Pharmaceuticals third-quarter 2022 financial results conference call. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Paul Little, Chief Financial Officer of Eledon. Mr. Little, please go ahead.
Paul Little - Eledon Pharmaceuticals, Inc. - CFO
Good afternoon, everyone, and thank you for joining Eledon's third-quarter 2022 operating and financial results conference call. Today, I'm joined by David-Alexandre Gros, Chief Executive Officer; Steve Perrin, our President and Chief Scientific Officer; and Jeff Bornstein, our Chief Medical Officer.
Earlier today, Eledon issued a press release announcing financial results for the third quarter ended September 30, 2022. You may access the release under the Investors tab on our company's website at eledon.com.
I would like to remind everyone that statements made during this conference call relating to Eledon's expected future performance, future business prospects, or future events or plans may
Q3 2022 Eledon Pharmaceuticals Inc Earnings Call Transcript
Nov 15, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers